BackZosano Pharma Overview

Zosano Pharma Total Assets

Latest total assets for ZSAN: $26M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$26.45M
↓ 59.75% YoYΔ $-39.27M vs prior year quarter

Peer average

Loading

Zosano Pharma Total Assets History

Loading

Zosano Pharma vs. peers: Total Assets Comparison

Loading

Zosano Pharma Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Zosano Pharma (ZSAN) FAQ

As of the most recent data (March 2022), ZSAN shows a total assets of $26M. That compares with $66M in the prior-year period — down 59.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ZSAN's total assets is now $26M (was $66M) — a 59.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Zosano Pharma is outperforming or lagging.

Tracking ZSAN's total assets over time shows whether Zosano Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $26M That compares with $66M in the prior-year period — down 59.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Zosano Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $26M) with ownership activity and broader fundamentals.

Zosano Pharma's total assets is $26M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.